Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$434K Buy
+3,594
New +$393K ﹤0.01% 777
2025
Q3
Sell
-6,942
Closed -$703K 885
2025
Q2
$703K Buy
6,942
+1,152
+20% +$117K ﹤0.01% 675
2025
Q1
$615K Sell
5,790
-32
-0.5% -$3.32K ﹤0.01% 681
2024
Q4
$638K Buy
5,822
+1,087
+23% +$126K ﹤0.01% 665
2024
Q3
$686K Buy
4,735
+567
+14% +$77.4K ﹤0.01% 681
2024
Q2
$608K Sell
4,168
-13,685
-77% -$1.92M ﹤0.01% 767
2024
Q1
$2.57M Buy
+17,853
New +$2.03M 0.01% 568
2021
Q4
Sell
-12,432
Closed -$1.78M 1026
2021
Q3
$1.78M Buy
+12,432
New +$1.71M 0.01% 771

Other funds holding CROX

Aviva's CROX Position: Q2 2026 in Review

Aviva opened a new position in Crocs (CROX) in Q2 2026: 3,594 shares worth $434K. The stake represents ﹤0.01% of the portfolio and ranks #777 among its holdings. This is a return to the name: Aviva previously reported a position in CROX as recently as Q2 2025.

Aviva first reported a position in CROX in Q3 2021 and has held it in 8 quarters since. The position peaked at $2.57M in Q1 2024. 502 funds tracked by Wall St. Rank hold CROX as of Q2 2026.

  • Aviva held 3,594 shares of Crocs worth $434K as of Q2 2026.
  • Crocs was a new Aviva position in Q2 2026.
  • Crocs made up ﹤0.01% of Aviva's portfolio in Q2 2026, its #777 holding.
  • Aviva first reported a position in Crocs in Q3 2021 and has held it in 8 quarters since.
  • Aviva's Crocs position peaked at $2.57M in Q1 2024.
  • 502 funds tracked by Wall St. Rank held Crocs as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.